NCT07206888

Brief Summary

This study aims to investigate recent developments in ultrasound signal processing to determine if these new techniques can enhance the visibility of important features of interest in breast ultrasound images. Ultrasound signals obtained from both standard ultrasound imaging and ultrasound imaging combined with light (also known as photoacoustic imaging) will be investigated.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
252

participants targeted

Target at P75+ for all trials

Timeline
130mo left

Started Apr 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
Apr 2017Jan 2037

Study Start

First participant enrolled

April 25, 2017

Completed
8.4 years until next milestone

First Submitted

Initial submission to the registry

September 23, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 3, 2025

Completed
11.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2037

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2037

Last Updated

October 14, 2025

Status Verified

October 1, 2025

Enrollment Period

19.7 years

First QC Date

September 23, 2025

Last Update Submit

October 13, 2025

Conditions

Keywords

cystmassdiagnostic screeningultrasoundmammography

Outcome Measures

Primary Outcomes (6)

  • Image quality

    compare advanced beamforming and benchmark against a conventional beamforming technique by measuring and comparing standard image quality metrics

    baseline

  • Number of microcalcifications

    baseline

  • Binary visibility of microcalcifications

    Clinicians (members of study team) will be shown images and record 'yes' if microcalcifications are present and 'no' if not.

    baseline

  • Subjective ratings

    Clinicians (members of study team) will be shown images and asked to provide subjective ratings of the images

    baseline

  • Distinction of mass contents: solid vs. fluid

    After examining the coherence measurements obtained from advanced beamforming techniques, the investigators will determine the ability of this quantitative information to distinguish between solid and fluid-filled masses

    baseline

  • Distinction of mass contents: benign vs. malignant

    After examining the coherence measurements obtained from advanced beamforming techniques, the investigators will determine the ability of this quantitative information to distinguish between solid malignant masses vs. solid benign masses

    baseline

Secondary Outcomes (4)

  • Number of true positives

    baseline

  • Number of false positives

    baseline

  • Number of true negatives

    baseline

  • Number of false negatives

    baseline

Interventions

ImagingDIAGNOSTIC_TEST

Ultrasound imaging or ultrasound imaging with light (i.e., photoacoustic imaging)

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Johns Hopkins Hospital

You may qualify if:

  • Female adults (age \>18 years) with at least one of the following:
  • Macrocalcification(s) detected in x-ray 2D or 3D mammography images
  • Macrocalcification(s) located next to cyst (or other identifiable landmark on an ultrasound image)
  • A cyst, mass, or finding detected in diagnostic/screening ultrasound or mammography

You may not qualify if:

  • (when performing ultrasound imaging only)
  • Children (age \< 18 years) are excluded
  • (when performing ultrasound imaging with light, i.e., optoacoustic imaging)
  • Children (age \< 18 years) are excluded
  • Is pregnant
  • Has open sores including insect bites, rash, poison ivy, and chafing on the skin of the ipsilateral breast
  • Is experiencing phototoxicity associated with currently taking, or having taken, photosensitizing agents within the previous 72 hours such as sulfonamides, ampicillin, tetracycline
  • Is currently undergoing phototherapy
  • Has a history of any photosensitive disease (e.g., porphyria, lupus erythematosus) or is undergoing treatment for a photosensitive disease and is experiencing photosensitivity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins Outpatient Center

Baltimore, Maryland, 21209, United States

Location

MeSH Terms

Conditions

Breast NeoplasmsBreast CystCalcinosisCystsArachnodactyly

Interventions

Diagnostic Imaging

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesCalcium Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsLimb Deformities, CongenitalMusculoskeletal AbnormalitiesMusculoskeletal DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Muyinatu Bell, PhD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2025

First Posted

October 3, 2025

Study Start

April 25, 2017

Primary Completion (Estimated)

January 1, 2037

Study Completion (Estimated)

January 1, 2037

Last Updated

October 14, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations